• Recursion Pharmaceuticals (NASDAQ:RXRX) Given "Buy" Rating at Needham & Company LLC

    Source: Buzz FX / 07 Nov 2024 09:26:16   America/New_York


    Recursion Pharmaceuticals (NASDAQ:RXRX) Given "Buy" Rating at Needham & Company LLC Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Recursion Pharmaceuticals ( NASDAQ:RXRX - Get Free Report ) 's stock had its "buy" ra
    Read more...
Share on,